Skip to main content
PMC home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 1999 Jul;81(1):F40–F44. doi: 10.1136/fn.81.1.f40

Outcome following pulmonary haemorrhage in very low birthweight neonates treated with surfactant

P Pandit, K O'Brien, E Asztalos, E Colucci, M Dunn
PMCID: PMC1720955  PMID: 10375361

Abstract

AIM—To determine if pulmonary haemorrhage after surfactant treatment increases short and long term morbidity and mortality in neonates weighing <1500 g at birth.
METHODS—Neonates weighing <1500 g at birth who developed pulmonary haemorrhage after surfactant treatment were identified from a database. Based on the change in FIO2, pulmonary haemorrhage was classified as mild, moderate, or severe. Controls were matched for birthweight, gestational age, Apgar scores and hospital. Chronic lung disease (CLD) was defined as the need for supplemental oxygen at 36 weeks of corrected gestational age.
RESULTS—From January 1990 to May 1994, 94 of 787 (11.9%) neonates treated with surfactant developed pulmonary haemorrhage. Ten were excluded because of incomplete data or lack of controls. Eighty four were included for further analysis; two acceptable matches were found in 75, while only one match was possible in nine. For the pulmonary haemorrhage group, the mean (SD) birthweight was 917 (238) g, gestational age 27 (1.9) weeks. Pulmonary haemorrhage was severe in 39 (46%), moderate in 22 (26%), and mild in 23 (27%). Moderate and severe pulmonary haemorrhage were associated with chronic lung disease or death, OR 4.4 (confidence interval 1.3-15.7) and OR 7.8 (CI 2.6-28), respectively, while mild pulmonary haemorrhage was not, OR 1.8 (CI 0.55-5.8). pulmonary haemorrhage was associated with major intraventricular haemorrhage (IVH), OR 3.1 (CI 1.5-6.4), but not with minor IVH, OR 1.3 (CI 0.6-2.6). In the survivors who could be assessed at ⩾2 years, the differences in neurodevelopmental outcome among the two groups were not significant.
CONCLUSIONS—In neonates treated with surfactant moderate and severe pulmonary haemorrhage is associated with an increased risk of death and short term morbidity. Pulmonary haemorrhage does not seem to be associated with increased long term morbidity.



Full Text

The Full Text of this article is available as a PDF (125.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Coffin C. M., Schechtman K., Cole F. S., Dehner L. P. Neonatal and infantile pulmonary hemorrhage: an autopsy study with clinical correlation. Pediatr Pathol. 1993 Sep-Oct;13(5):583–589. doi: 10.3109/15513819309048246. [DOI] [PubMed] [Google Scholar]
  2. Enhorning G., Shennan A., Possmayer F., Dunn M., Chen C. P., Milligan J. Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: a randomized clinical trial. Pediatrics. 1985 Aug;76(2):145–153. [PubMed] [Google Scholar]
  3. Garland J., Buck R., Weinberg M. Pulmonary hemorrhage risk in infants with a clinically diagnosed patent ductus arteriosus: a retrospective cohort study. Pediatrics. 1994 Nov;94(5):719–723. [PubMed] [Google Scholar]
  4. Hoekstra R. E., Jackson J. C., Myers T. F., Frantz I. D., 3rd, Stern M. E., Powers W. F., Maurer M., Raye J. R., Carrier S. T., Gunkel J. H. Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome. Pediatrics. 1991 Jul;88(1):10–18. [PubMed] [Google Scholar]
  5. Long W., Corbet A., Cotton R., Courtney S., McGuiness G., Walter D., Watts J., Smyth J., Bard H., Chernick V. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group. N Engl J Med. 1991 Dec 12;325(24):1696–1703. doi: 10.1056/NEJM199112123252404. [DOI] [PubMed] [Google Scholar]
  6. Long W., Thompson T., Sundell H., Schumacher R., Volberg F., Guthrie R. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I. J Pediatr. 1991 Apr;118(4 Pt 1):595–605. doi: 10.1016/s0022-3476(05)83388-8. [DOI] [PubMed] [Google Scholar]
  7. Northway W. H., Jr Observations on bronchopulmonary dysplasia. J Pediatr. 1979 Nov;95(5 Pt 2):815–818. doi: 10.1016/s0022-3476(79)80441-2. [DOI] [PubMed] [Google Scholar]
  8. Pandit P. B., Dunn M. S., Colucci E. A. Surfactant therapy in neonates with respiratory deterioration due to pulmonary hemorrhage. Pediatrics. 1995 Jan;95(1):32–36. [PubMed] [Google Scholar]
  9. Papile L. A., Burstein J., Burstein R., Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978 Apr;92(4):529–534. doi: 10.1016/s0022-3476(78)80282-0. [DOI] [PubMed] [Google Scholar]
  10. Perlman J. M., Rollins N., Burns D., Risser R. Relationship between periventricular intraparenchymal echodensities and germinal matrix-intraventricular hemorrhage in the very low birth weight neonate. Pediatrics. 1993 Feb;91(2):474–480. [PubMed] [Google Scholar]
  11. Raju T. N., Langenberg P. Pulmonary hemorrhage and exogenous surfactant therapy: a metaanalysis. J Pediatr. 1993 Oct;123(4):603–610. doi: 10.1016/s0022-3476(05)80963-1. [DOI] [PubMed] [Google Scholar]
  12. Rowe S., Avery M. E. Massive pulmonary hemorrhage in the newborn. II. Clinical considerations. J Pediatr. 1966 Jul;69(1):12–20. doi: 10.1016/s0022-3476(66)80355-4. [DOI] [PubMed] [Google Scholar]
  13. Shennan A. T., Dunn M. S., Ohlsson A., Lennox K., Hoskins E. M. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics. 1988 Oct;82(4):527–532. [PubMed] [Google Scholar]
  14. Sly P. D., Drew J. H. Massive pulmonary haemorrhage: a cause of sudden unexpected deaths in severely growth retarded infants. Aust Paediatr J. 1981 Mar;17(1):32–34. doi: 10.1111/j.1440-1754.1981.tb00010.x. [DOI] [PubMed] [Google Scholar]
  15. Vaucher Y. E., Harker L., Merritt T. A., Hallman M., Gist K., Bejar R., Heldt G. P., Edwards D., Pohjavuori M. Outcome at twelve months of adjusted age in very low birth weight infants with lung immaturity: a randomized, placebo-controlled trial of human surfactant. J Pediatr. 1993 Jan;122(1):126–132. doi: 10.1016/s0022-3476(05)83505-x. [DOI] [PubMed] [Google Scholar]
  16. Walsh M. C., Kliegman R. M. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am. 1986 Feb;33(1):179–201. doi: 10.1016/S0031-3955(16)34975-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Yeung C. Y. Massive pulmonary hemorrhage in neonatal infection. Can Med Assoc J. 1976 Jan 24;114(2):135–138. [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood. Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES